Issues
Get Email Alerts
Ask the Expert: A Regulatory Perspective on Clinical Trials for Pulmonary Arterial Hypertension
Christine Garnett, PharmD, Norman Stockbridge, MD, PhD
Novel and Relevant Mechanistic Pathways
Martin R. Wilkins, MD, FRCP, Marlene Rabinovitch, MD
Limitations and Flaws of Preclinical Pulmonary Hypertension Studies
Tsukasa Shimauchi, MD, PhD, François Potus, PhD, Sébastien Bonnet, PhD, FAHA, Steeve Provencher, MD, MSc, FRCPC, Roxane Paulin, PhD, Olivier Boucherat, PhD
